A Study of Administration of Trastuzumab (Herceptin) by a Single-use Injection Device Versus a Handheld Syringe
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
This randomized, open-label, parallel, 2-arm, multicenter study will compare the
administration of Herceptin (trastuzumab) with a single-use injection device versus a
handheld syringe in healthy male volunteers. The volunteers will receive a single dose of 600
mg Herceptin. The anticipated time of the study is 21 weeks.